Astex Pharmaceuticals is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.
•Fiscal strength with significant cash, ongoing revenues and potential milestone payments
•Productive partnerships with top-tier pharmaceutical companies
•Rich product portfolio with multiple drugs in clinical development
•Visionary leadership backed by a world-class management team
Oncology Focused. We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and hematology.
Financially Strong. We are a publicly traded pharmaceutical company with strong cash reserves and royalty revenues from the sales of our product DACOGEN®. In addition, our partnerships could deliver significant product milestones and future royalties.